| Date |
Title |
Rating |
| 2010-08-31 |
Unpleasant short term side-effects of sunburn dont put off sun-seeking Brits |
None |
| 2010-08-31 |
pSivida announces FDA Priority Review status for Iluvien NDA |
None |
| 2010-08-31 |
Stromedix's STX-100 receives orphan drug status from FDA for treatment of IPF |
None |
| 2010-08-31 |
Halozyme identifies strategy to reintroduce HYLENEX |
None |
| 2010-08-31 |
Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list for depression treatment |
None |
| 2010-08-31 |
TearLab and AMO Canada enter cooperative marketing agreement |
None |
| 2010-08-31 |
Nutritional recommendations for management of sarcopenia published |
None |
| 2010-08-31 |
EDIMS licenses First DataBank's National Drug Data File Plus database |
None |
| 2010-08-31 |
New report on global dermatology market |
None |
| 2010-08-31 |
Bionovo receives positive guidance for Menerba drug candidate |
None |
| 2010-08-31 |
SCOLR Pharma signs sales support agreement with Emerson Group |
5 |
| 2010-08-31 |
Ralphs Grocery Company to offer seasonal flu vaccine at $25 |
None |
| 2010-08-31 |
Valeant Pharmaceuticals announces new FDA PDUFA goal date for ezogabine |
None |
| 2010-08-31 |
Using clopidogrel, PPIs increases cardiac damage risk: Study |
5 |
| 2010-08-31 |
BARDA awards $27 million contract to Achaogen for antibiotic development |
None |
| 2010-08-31 |
Over use of decongestants by women leads to preterm birth delivery: Study |
None |
| 2010-08-31 |
Salix Pharmaceuticals to settle patent litigation of Novel's generic version of MOVIPREP |
None |
| 2010-08-31 |
Roche's MabThera continues to dwarf recently launched monoclonal antibodies: Report |
None |
| 2010-08-31 |
Achaogen receives contract from BARDA for developing ACHN-490 antibiotic treatment |
None |
| 2010-08-31 |
FDA grants Priority Review status to Alimera Sciences' Iluvien for diabetic macular edema |
None |
| 2010-08-31 |
FDA extends Prescription Drug User Fee Act date for ezogabine |
None |
| 2010-08-31 |
Intendis granted rights to KYTHERA's ATX-101 candidate for minimally-invasive fat reduction outside US, Canada |
None |
| 2010-08-30 |
Greater Sacramento Specialty Pharmacy acquired by The Apothecary Shops |
5 |
| 2010-08-30 |
H. D. Smith becomes primary supplier of pharmaceutical products for NAPPSA pharmacies |
None |
| 2010-08-30 |
Cannabis Science seeks entry into European medical cannabis market |
None |
| 2010-08-30 |
Perfadex improves survival in lung tranplant patients: Study |
None |
| 2010-08-30 |
Nanotherapeutics files NanoDTPA IND for treatment of radiation exposure |
None |
| 2010-08-30 |
Eisai receives new action date for FDA priority review of eribulin mesylate NDA for metastatic breast cancer |
None |
| 2010-08-30 |
FDA approves additional strengths of SOLODYN for inflammatory lesions treatment |
None |
| 2010-08-30 |
Children, teens need good health before the start of new school year, says medical director |
None |
| 2010-08-30 |
CAMH welcomes Ontario's narcotics strategy to address inappropriate use of prescription opioids |
None |
| 2010-08-30 |
Independent drugstore lobby demands more 'transparency' for PBMs in pharmacy supply chain |
None |
| 2010-08-30 |
New research contradicts previous reports on blood-thinner clopidogrel |
None |
| 2010-08-30 |
Promising skin cancer drug in the near horizon |
None |
| 2010-08-30 |
Misuse of OTC medicines increases risk for children |
None |
| 2010-08-30 |
Study reveals impact of genetic make-up on response to oral antiplatelet treatment ticagrelor |
None |
| 2010-08-30 |
Study finds common risk factors linked with painkiller addiction |
None |
| 2010-08-27 |
Authorities arrest more than 80 people, seize 10 tons of counterfeit meds in E. Africa |
None |
| 2010-08-27 |
Montana Gov. seeks cheaper drugs for residents; Legal immigrants may lose health insurace in Mass. |
None |
| 2010-08-27 |
New alchemy module allows healthcare providers to verify, comply with state and federal prescription drug regulations |
None |
| 2010-08-27 |
FDA approves Novartis' Tekamlo for treatment of high blood pressure |
None |
| 2010-08-27 |
Genentech receives FDA Refuse to File letter for accelerated approval of trastuzumab-DM1 BLA |
None |
| 2010-08-27 |
Ricerca Biosciences completes purification of an API under cGMP controls |
None |
| 2010-08-27 |
Wall Street Journal reports on pharma's growing interest in emerging markets |
None |
| 2010-08-27 |
Target offers seasonal flu vaccine at $24 |
5 |
| 2010-08-27 |
Disulfiram drug effective in treating cocaine addiction: Research |
None |
| 2010-08-27 |
SYSPRO ERP solution support pharmaceutical manufacturers to new FDA regulation |
None |
| 2010-08-27 |
FDA denies accelerated approval of Genentech's trastuzumab-DM1 (T-DM1) BLA for metastatic breast cancer |
5 |
| 2010-08-27 |
Coalition of organizations request FDA to govern antibiotic usage in food animal production |
None |
| 2010-08-27 |
Study finds PCV7 vaccine reduces bacterial pneumonia infection in children |
None |
| 2010-08-27 |
NICE suggests bortezomib, thalidomide for multiple myeloma patients |
None |
| 2010-08-26 |
Aethlon Medical receives approval for Chronic HCV Infection treatment |
None |
| 2010-08-26 |
Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets |
None |
| 2010-08-26 |
Seven year Aspirin for cancer trial |
None |
| 2010-08-26 |
AARP Report finds increase in brand-name drug costs outstrips inflation |
None |
| 2010-08-26 |
BioTrends Research Group report provides in-depth view of kidney transplantation market |
None |
| 2010-08-26 |
Xcellerex, SK Chemicals sign memorandum of understanding to expand vaccine business in Korea |
5 |
| 2010-08-26 |
Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS |
None |
| 2010-08-26 |
FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddlers |
None |
| 2010-08-26 |
Momenta Pharmaceuticals provides update on generic Lovenox litigation |
None |
| 2010-08-26 |
Affordable Care Act that mandates free preventative services goes into effect in September |
None |
| 2010-08-26 |
FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis |
None |
| 2010-08-26 |
FDA notification confirms acyclovir Lauriad for oro-facial herpes labialis |
None |
| 2010-08-26 |
Giant Eagle installs RxSafe 1800 pharmacy workflow automation system |
None |
| 2010-08-26 |
PCMA reports increase in retail prices of popular brand-name drugs |
None |
| 2010-08-26 |
Transparency needed in administration of drug benefits by pharmacy benefit managers |
None |
| 2010-08-26 |
Henry Ford Health System introduces 'Pill Timer' for medication management |
None |
| 2010-08-26 |
Treating metastatic melanoma tumors with specific genetic signature shows promising results |
None |
| 2010-08-26 |
TimeOut Capsules can dangerously lower blood pressure, FDA warns |
None |
| 2010-08-26 |
Prescription drug abuse soars despite state monitoring programs |
None |
| 2010-08-26 |
Europe's pharma sector faces increasing challenges |
None |
| 2010-08-26 |
Biogen to publish data on two-step assay for anti-JC virus antibody detection |
5 |
| 2010-08-26 |
FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy |
None |
| 2010-08-25 |
New syndicated report highlights medical management of noninfectious uveitis |
None |
| 2010-08-25 |
Somaxon Pharmaceuticals, Procter & Gamble to co-promote Silenor |
None |
| 2010-08-25 |
Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter |
None |
| 2010-08-25 |
Perrigo obtains FDA clearance to manufacture infant formula products |
None |
| 2010-08-25 |
Shire receives FDA ruling on Pentasa Citizen's Petition |
None |
| 2010-08-25 |
Inspire Pharmaceuticals, Allergan sign amended agreement for ophthalmic formulations |
None |
| 2010-08-25 |
Warner Chilcott receives FDA response to citizen petition for ASACOL and ASACOL HD products |
None |
| 2010-08-25 |
WHO grants prequalification status to pneumococcal vaccine, paving way for U.N. procurement |
None |
| 2010-08-25 |
OXIS International to introduce new ergothioneine-based products for joint health and healthy aging |
None |
| 2010-08-25 |
Physicians decrease LABA/ICS combination therapy for asthma treatment: Survey |
None |
| 2010-08-25 |
Study: No association between first-trimester exposure to antiherpetic antiviral drugs and major birth defects |
None |
| 2010-08-25 |
Cedarlane to distribute Pfenex's high value reagent proteins in Canada, U.S. |
None |
| 2010-08-25 |
CAS researchers confirm Gleevec’s first generation drug targets chronic myelogenous leukemia |
None |
| 2010-08-25 |
Simulations Plus launches Version 7.0 of GastroPlus software for pharmaceutical industry |
None |
| 2010-08-25 |
Study finds measurable immunity to pandemic H1N1 virus in Norway population |
None |
| 2010-08-25 |
Two diabetes medications increase risk of heart attack, failure: Study |
None |
| 2010-08-25 |
Kamada, Baxter enter distribution and manufacturing agreement for Glassia Alpha-1 Antitrypsin Product |
None |
| 2010-08-25 |
Researchers identify novel approach to decrease glioblastoma multiforme recurrence |
5 |
| 2010-08-25 |
SureGene collaborates with Medco Health Solutions to conduct REST study |
None |
| 2010-08-25 |
Prollenium enters supply and distribution partnership with Canderm for Ovita HV dermal filler |
None |
| 2010-08-25 |
Survey finds women interested in human papillomavirus vaccination |
None |
| 2010-08-25 |
FDA grants Fast Track Designation to Celsion's ThermoDox for liver cancer treamtment |
None |
| 2010-08-25 |
Advanced Life Sciences seeks government funding for development of Restanza antibiotic |
None |
| 2010-08-25 |
BioAlliance Pharma launches Oravig drug in the U.S. market |
None |
| 2010-08-25 |
NICE draft guidance rejects cancer drug bevacizumab |
None |
| 2010-08-24 |
3SBio and Isotechnika enter strategic agreement for voclosporin in China |
None |
| 2010-08-24 |
Aileron Therapeutics, Roche partner to develop, commercialise Stapled Peptide Therapeutics |
None |
| 2010-08-24 |
Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients |
None |
| 2010-08-24 |
Deutsches Ärzteblatt International presents new PRISCUS List |
None |
| 2010-08-24 |
Department of Health to hold vaccination drive for whooping cough |
None |
| 2010-08-24 |
OSDD program aims to develop new drug for tuberculosis |
None |
| 2010-08-24 |
Medivir appoints Daewoong as South Korean distributor for Xerclear |
None |
| 2010-08-24 |
Removing corticosteroid regimen after surgery results in better graft survival rates |
None |
| 2010-08-24 |
Baxter announces definitive agreement with Kamada for GLASSIA alpha1-proteinase inhibitor |
None |
| 2010-08-24 |
AP reports on efforts to monitor authenticity of antimalarials, other drugs in Africa |
None |
| 2010-08-24 |
Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification |
None |
| 2010-08-23 |
Publix Super Markets to introduce flu immunization program |
None |
| 2010-08-23 |
Preclinical studies of BIND-014 to be presented at ACS National Meeting |
None |
| 2010-08-23 |
Flu vaccine to be available at local pharmacies, doctor's offices |
None |
| 2010-08-23 |
Novo Nordisk reaches exclusive agreement to market Vagifem 10 mcg |
None |
| 2010-08-23 |
FDA approves Alexion's Rhode Island manufacturing facility as commercial supply source for Soliris |
None |
| 2010-08-23 |
Getinge's vascular graft production unit receives warning letter from FDA |
None |
| 2010-08-23 |
Researchers find medication for diabetes, smoking cessation |
None |
| 2010-08-23 |
Epicept receives refusal to file letter on new drug application |
None |
| 2010-08-23 |
New antisense drugs may help treat accidental infections: Study |
None |
| 2010-08-23 |
Hospira Japan receives approval for long term use of Precedex IV sedative |
None |
| 2010-08-22 |
Hepatitis E vaccine successful in clinical trial: Study |
None |
| 2010-08-21 |
Immunization rate increases among teens: NIS report |
None |
| 2010-08-21 |
NHS Stop Smoking Services helps 373,954 people to quit smoking during 2009-10 |
None |
| 2010-08-21 |
US oncology announces its contributions in development of 42 novel cancer therapies |
None |
| 2010-08-21 |
WHO calls upon countries to be alert to antimicrobial resistance |
None |
| 2010-08-21 |
Scientists identify compound to treat Chagas' disease |
None |
| 2010-08-21 |
Impax confirms initiation of challenge of patents listed by MSP Singapore for VYTORIN |
None |
| 2010-08-21 |
Combination of 2 FDA approved drugs eliminate HIV infection |
5 |
| 2010-08-21 |
USPTO to allow patent for Advaxis’s new vaccine technology |
None |
| 2010-08-21 |
FDA extends review on Acetadote for non-acetaminophen acute liver failure |
None |
| 2010-08-20 |
Tasigna receives approval for chronic myeloid leukemia in Canada |
None |
| 2010-08-20 |
Education and caution needed before taking nutritional supplements to reduce cancer risks |
None |
| 2010-08-20 |
Ohio appeals court reinstates claim that diet drug Redux should not have been marketed |
None |
| 2010-08-20 |
Cerulean Pharma to assemble scientific experts at ACS National Meeting symposium |
None |
| 2010-08-20 |
FDA Advisory Committee votes in favor of expanding pain indications for Eli Lilly's Cymbalta |
None |
| 2010-08-20 |
Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients |
None |
| 2010-08-20 |
Research marks new direction to treat Pneumocystis, inflammatory diseases |
None |
| 2010-08-20 |
FDA grants priority review designation of BENLYSTA for systemic lupus erythematosus treatment |
None |
| 2010-08-20 |
Gilead receives Notice Letter of Sigmapharm's ANDA submission for generic Hepsera |
None |
| 2010-08-20 |
Quality issue roundup: J & J revamping controls; The odds for orthopedic surgery; Automatic prescription refills and patient compliance |
None |
| 2010-08-19 |
Scientists suggest combination vaccine prevents pertussis |
None |
| 2010-08-19 |
Novartis sales representatives increase calls to healthcare providers by 7%: SDI report |
None |
| 2010-08-19 |
PharmaVentures announces global expansion of PharmaDeals Agreements |
None |
| 2010-08-19 |
Effects of illegal drugs on health |
4.2 |
| 2010-08-19 |
Treatment with DMARDs reduces rheumatoid arthritis disability: Study |
None |
| 2010-08-19 |
USFDA approves Sun Pharma's generic Venlafaxine Hydrochloride Extended Release tablets ANDA |
None |
| 2010-08-19 |
Scientists suggest immunization against oncogenic herpesviruses can prevent cancer |
None |
| 2010-08-19 |
New clues to molecular action of Alzheimer's drug memantine |
None |
| 2010-08-19 |
Scientists reveal lab approach method to treat neuroblastoma in children |
None |
| 2010-08-19 |
FDA accepts to review Bristol-Myers Squibb's ipilimumab for melanoma |
None |
| 2010-08-19 |
FDA approves CSL Behring's sBLA to extend shelf life of Hizentra from 18 to 24 months |
None |
| 2010-08-18 |
USPTO grants Collegium second patent for tamper-resistant DETERx formulation platform |
None |
| 2010-08-18 |
Wound Management Technologies' CellerateRX introduced at DFWG congress in South Africa |
None |
| 2010-08-18 |
NASN encourages parents to vaccinate their children against meningococcal disease |
None |
| 2010-08-18 |
Experts to discuss the problem of antibiotic resistance |
None |
| 2010-08-18 |
Pharmacies in Massachusetts to make available lock boxes for sale |
None |
| 2010-08-18 |
XOMA sells royalty interest in CIMZIA |
None |
| 2010-08-18 |
FDA grants orphan drug designation to NephRx's lead product NX001 |
None |
| 2010-08-18 |
Study finds pharmaceuticals as a two-tier market for producing 'lemons' and serious harm |
5 |
| 2010-08-18 |
Repros Therapeutics requests Type B Meeting to review Androxal Phase III protocols |
None |
| 2010-08-18 |
Equatorial Guinea launches cholera, measles vaccination campaign to improve health services |
None |
| 2010-08-18 |
Pharmacists in all states authorized to administer influenza vaccines |
None |
| 2010-08-18 |
Physician recommends vaccination for Meningitis before children start school |
None |
| 2010-08-18 |
Study shows increase in IL-6 secretion can reduce Tarceva sensitivity to treat lung tumor cells |
None |
| 2010-08-18 |
NACTN receives grant to expand spinal cord injury research |
None |
| 2010-08-18 |
Emerson Ecologics announces exclusive distribution of EcoNugenics' ProstaCaid supplement |
None |
| 2010-08-18 |
Pharmacy drug information confusing or lacking, study says |
None |
| 2010-08-18 |
NCI grants SBIR award to MabVax Therapeutics |
None |
| 2010-08-18 |
BioMarin Pharmaceutical acquires ZyStor Therapeutics, furthers development of ZC-701 for Pompe disease |
None |
| 2010-08-17 |
Merck's SIMPONI anti-TNF therapy now reimbursed in New Brunswick, Nova Scotia and Alberta |
None |
| 2010-08-17 |
QRxPharma receives Frost & Sullivan's 2010 New Product Innovation of the Year Award for MoxDuo IR opiod |
None |
| 2010-08-17 |
Pisgah Labs receives Notice of Allowance for new patent relating to thyroid hormone drugs |
5 |
| 2010-08-17 |
Sport Endurance develops new formula that enables safe consumption of Creatine |
None |
| 2010-08-17 |
FDA considers dropping Avastin approval, approves five-day emergency contraception pill |
None |
| 2010-08-17 |
FDA issues Proposal to Withdraw Marketing Approval for orthostatic hypotension drug midodrine hydrochloride |
None |
| 2010-08-17 |
Ill effects of methamphetamine |
4 |
| 2010-08-17 |
Global vaccine sales up 16% in 2009, report says |
None |
| 2010-08-17 |
Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue |
None |
| 2010-08-16 |
Amphetamine abuse associated with increased risk of aortic dissection |
2 |
| 2010-08-16 |
CVS/Pharmacy opens new store in Omaha |
None |
| 2010-08-16 |
Jiangbo receives Shandong FDA approval to market Felodipine SR tablets |
None |
| 2010-08-16 |
Cortex second-quarter net loss decreases to $0.04 per share |
None |
| 2010-08-16 |
KemPharm receives patent for LAT prodrug technology for Attention Deficit – Hyperactivity Disorder treatment |
None |
| 2010-08-16 |
Green Cross receives KFDA approval to manufacture, market i.v. peramivir: BioCryst Pharmaceuticals |
None |
| 2010-08-16 |
Cangene to focus commercialization efforts on key markets |
None |
| 2010-08-16 |
Genentech asserts SPC non-infringement of products in Europe, seeks response from PDL |
None |
| 2010-08-16 |
Survey: Majority of U.S. pharmaceutical companies develop drugs for mental illness |
None |
| 2010-08-16 |
Frost & Sullivan: Pharmaceutical industry in east African countries earns revenue from infectious disease, cancer. |
None |
| 2010-08-16 |
CTI announces EMEA's validation of expanded PIP for pixantrone |
None |
| 2010-08-16 |
R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical |
None |
| 2010-08-16 |
Watson to launch ella emergency contraceptive in fourth-quarter 2010 |
None |
| 2010-08-16 |
US WorldMeds announces acquisition of Solstice Neurosciences for $35M |
None |
| 2010-08-16 |
FDA's labeling of Ella as 'Emergency Contraceptive' misleading, says FRC |
None |
| 2010-08-16 |
MeCP2 protein regulates properties of psychostimulant drugs: Research |
None |
| 2010-08-16 |
Insurers defend limited-benefit health policies in fight over proposed restrictions |
None |
| 2010-08-16 |
Avenue to Access provides free prescription-size tube of ZITHRANOL-RR to stable plaque psoriasis patients |
None |
| 2010-08-16 |
FDA approves ellaOne for emergency contraception |
None |
| 2010-08-16 |
Daily dose of aspirin may reduce prostate cancer risk: US Study |
None |
| 2010-08-13 |
Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin |
None |
| 2010-08-13 |
Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million |
None |
| 2010-08-13 |
Lamictal can cause aseptic meningitis: FDA |
None |
| 2010-08-13 |
Eli Lilly to appeal against U.S. District Court ruling in Strattera patent litigation |
None |
| 2010-08-13 |
UMass Memorial selects McKesson's CytoCare robot to automate compounding of hazardous IV drugs |
None |
| 2010-08-13 |
Study identifies use of acetaminophen may increase asthma symptoms in adults |
None |
| 2010-08-13 |
Mass. docs will soon track patients who abuse prescription drugs; Wis. Catholic Church employees now eligible for birth control |
None |
| 2010-08-13 |
Prices drop for PBMs; Pharmacy lobby opposes survey regarding Medicaid prices |
None |
| 2010-08-13 |
Cancer Research Technology grants Valirx global rights to develop VAL 201 for cancer treatment |
2.5 |
| 2010-08-13 |
Tracking heart rate can provide important marker of health issues: Research |
None |
| 2010-08-13 |
Study examines comparative value of different blood pressure lowering medications |
4 |
| 2010-08-13 |
Antares Pharma second-quarter total revenue increases 78% to $3.1 million |
None |
| 2010-08-12 |
Fast food outlets can provide statin drugs to help customers neutralise heart disease: Researchers |
None |
| 2010-08-12 |
Aeterna Zentaris second-quarter revenues decrease to $5.6 million |
None |
| 2010-08-12 |
Amorfix first-quarter fiscal 2011 net loss from operations increases to $1,724,745 |
None |
| 2010-08-12 |
Pharmasset receives fast track designation from FDA for PSI-7977 |
None |
| 2010-08-12 |
Labopharm second-quarter total revenue increases to $6.8 million |
None |
| 2010-08-12 |
NextWave Pharmaceuticals, Tris Pharma sign agreement to enhance CNS product portfolio |
None |
| 2010-08-12 |
International cultivator wins Canada's prestigious medical marijuana quality award |
None |
| 2010-08-12 |
FDA advisory committee votes in favor of Ezogabine |
None |
| 2010-08-12 |
Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPs |
None |
| 2010-08-12 |
Simcere subsidiary receives Chinese SFDA approval to manufacture and market Palonosetron |
None |
| 2010-08-12 |
Wound Management Technologies introduces CellerateRX wound care collagen product in South Africa |
None |
| 2010-08-12 |
Study finds lithium drugs not effective for amyotrophic lateral sclerosis treatment |
None |
| 2010-08-12 |
Intellect Neurosciences receives patent for insulin sensitizer drugs |
None |
| 2010-08-12 |
Advaxis, Vibalogics to develop storage-stable formulation for live Listeria vaccines |
None |
| 2010-08-12 |
AHF led sustained advocacy campaign leads to BMS's offer of discounts in AIDS drug pricing |
None |
| 2010-08-11 |
Advanced Life Sciences second-quarter net loss decreases to $2.1 million |
5 |
| 2010-08-11 |
Nabi Biopharmaceuticals completes sale of PentaStaph vaccine candidate to GSK |
None |
| 2010-08-11 |
Repros receives US patent for Androxal |
5 |
| 2010-08-11 |
OptiNose's bi-directional nasal device delivering fluticasone effective in reducing nasal polyps in CRS patients |
None |
| 2010-08-11 |
PregLem announces exclusive in licensing agreement with Merck Serono for Bentamapimod |
None |
| 2010-08-11 |
GenSpera issued additional patent for G-202 |
None |
| 2010-08-11 |
Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone |
None |
| 2010-08-11 |
Jazz Pharmaceuticals second-quarter net product sales increase 49% to $39.5 million |
None |
| 2010-08-11 |
Intellect Neurosciences receives patent for Alzheimer's disease vaccine |
None |
| 2010-08-11 |
Advanced Life Sciences reaches SPA agreement with FDA for Restanza Phase 3 study |
None |
| 2010-08-11 |
NovoSeven RT in 8 mg vial for hemophilia A or B with inhibitors receives FDA approval |
None |
| 2010-08-11 |
Study shows physicians reluctant to use finasteride for prostate cancer |
None |
| 2010-08-11 |
Education, changes in reimbursement practices can reduce inappropriate antibiotic usage: Study |
2 |
| 2010-08-11 |
FDA approves longer Valcyte therapy for CMV disease in adult kidney transplant patients |
None |
| 2010-08-11 |
Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S. |
4 |
| 2010-08-11 |
Noven enters agreement to acquire global rights to ADHD drug Daytrana from Shire |
None |
| 2010-08-11 |
Study reveals no evidence of link between bisphosphonates to esophageal cancer risk |
5 |
| 2010-08-10 |
CADTH Review Panel releases recommendations for Biologic Response Modifier Agents for Adults with RA |
None |
| 2010-08-10 |
FDA grants Orphan Drug Designation to YM BioSciences' JAK1/2 inhibitor |
None |
| 2010-08-10 |
Weifang Shengtai to supply Kelun with 10,000 tons of dextrose monohydrate injection grade |
None |
| 2010-08-10 |
Transcept Pharmaceuticals second-quarter net loss decreases to $2.06 million |
None |
| 2010-08-10 |
Unigene second-quarter revenue decreases to $3.03 million |
None |
| 2010-08-10 |
Systemic lupus erythematosus drug market to quadruple from $400 million in 2009 to over $1.6 billion in 2019 |
None |
| 2010-08-10 |
Anika second-quarter product revenue increases 56% to $13.7 million |
None |
| 2010-08-10 |
Endo to acquire Penwest for $5.00 per share |
None |
| 2010-08-10 |
Psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019: Pharmacor 2010 |
5 |
| 2010-08-09 |
FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patients |
None |
| 2010-08-09 |
Progenics second-quarter total revenue decreases to $2.3 million |
None |
| 2010-08-09 |
FDA accepts Salix's XIFAXAN550 sNDA for Priority Review |
None |
| 2010-08-09 |
Dr Reddy’s launches first generic darbepoetin alfa |
None |
| 2010-08-09 |
Health Canada approves first targeted biological therapy to show survival benefit in stomach cancer |
None |
| 2010-08-09 |
Clinical Data first-quarter gross revenue increases 52% to $6.2 million |
None |
| 2010-08-09 |
AOBO to launch Yin Yang balancing medication Pai Du Qing Zhi Tablet |
None |
| 2010-08-09 |
AOBO announces commercial launch of osteoporosis drug Yi Shen Jian Gu Gel |
None |
| 2010-08-09 |
Repros Therapeutics receives positive feedback from FDA for Androxal |
None |
| 2010-08-09 |
An overview of SRVP annual meeting |
None |
| 2010-08-09 |
AstraZeneca reaches agreements in principle on monetary terms for SEROQUEL product liability |
None |
| 2010-08-09 |
Anti-viral drug addition to standard treatment regimen increases cure rate for hepatitis C |
None |
| 2010-08-09 |
Study finds selective serotonin reuptake inhibitors not beneficial for autistic children |
None |
| 2010-08-07 |
45-year-old Hummelstown patient takes on FDA over Johnson & Johnson’s antibiotic Levaquin |
None |
| 2010-08-07 |
Ironwood provides investor update for second-quarter 2010 |
None |
| 2010-08-07 |
EpiCept second-quarter net loss decreases to $4.9 million |
None |
| 2010-08-07 |
Opexa Therapeutics aims to complete planned experiments, develop clinical study protocols |
None |
| 2010-08-07 |
BMS to join ranks of AIDS drug companies to offer price concessions |
None |
| 2010-08-07 |
Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs |
None |
| 2010-08-07 |
FDA confirms Advisory Committee meeting date for lorcaserin NDA review |
None |
| 2010-08-07 |
FDA seeks ban on Regenerative Sciences for violating cGMP |
None |
| 2010-08-07 |
Alkermes reports $42.3 million revenue for first-quarter fiscal 2011 |
None |
| 2010-08-07 |
Cornerstone announces ANDA filing for generic Tussionex |
None |
| 2010-08-07 |
Walgreens launches Pharmacy Chat for 24/7 online access |
None |
| 2010-08-07 |
FDA approves Lannett's ANDA for Ondansetron Injection |
None |
| 2010-08-07 |
Progenics announces EMA CHMP positive opinion for RELISTOR in pre-filled syringes |
None |
| 2010-08-07 |
FDA declines to grant Levulan PDT Orphan Designation: DUSA Pharmaceuticals |
None |
| 2010-08-06 |
Elsevier Properties congratulates Stewart for achieving Lectureship |
None |
| 2010-08-06 |
ViroPharma announces data on safety, efficacy of Cinryze to treat acute angioedema attacks |
2 |
| 2010-08-06 |
Threshold Pharmaceuticals reports net loss of $0.3M for second-quarter 2010 |
None |
| 2010-08-06 |
Fidaxomicin, CDA1/CDB1 effective for treating CDI : Report |
None |
| 2010-08-06 |
TEMPO study recommends early administration of Azilect in PD patients |
4 |
| 2010-08-06 |
Studies show biological agents play important role in maintaining remission in Crohn's disease |
None |
| 2010-08-06 |
New research on use of medicine, diet to prevent UV-induced skin cancer |
None |
| 2010-08-06 |
Summer Academy Meeting highlights benefits of HPV, Herpes Zoster vaccines |
None |
| 2010-08-06 |
Study: Drug control efforts have caused a drop in methamphetamine treatment admissions in Mexico |
None |
| 2010-08-06 |
Cobalis, BESPHarma partner to launch national distribution program for PreHistin Allergy Defense Formula |
None |
| 2010-08-05 |
Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulation |
None |
| 2010-08-05 |
Biovail second-quarter total revenues increase 23% to $238.8 million |
None |
| 2010-08-05 |
New study reinforces need for national catastrophic drug plan in Canada for cancer patients |
None |
| 2010-08-05 |
Inspire second-quarter total revenue increases 18% to $27.3 million |
None |
| 2010-08-05 |
Columbia second-quarter net revenues from progesterone products increase 48% to $8.4 million |
None |
| 2010-08-05 |
CEL-SCI produces and fills first lot of Multikine |
5 |
| 2010-08-05 |
CTI second-quarter total net operating expenses decrease to $20.0 million |
None |
| 2010-08-05 |
Nature News examines how scientists, farmers are working to meet the growing demand for artemisinin |
None |
| 2010-08-05 |
Elusys awarded second contract to develop Anthim for treatment of anthrax infection |
None |
| 2010-08-05 |
Alnylam second-quarter revenues increase to $26.6 million |
None |
| 2010-08-05 |
Shire proposes acquisition of Movetis for fully diluted equity purchase price of EUR428 million |
None |
| 2010-08-05 |
Lux Biosciences receives CRL for Voclosporin |
None |
| 2010-08-05 |
Daiichi Sankyo reaches agreement with Apotex to settle Evoxac patent litigation |
None |
| 2010-08-05 |
Long-term exposure to valproate leads to bone loss: Study |
5 |
| 2010-08-05 |
EEG patterns can predict schizophrenia patients' response to clozapine therapy |
None |
| 2010-08-05 |
Scientist invents new approach to boost body's response to vaccinations |
None |
| 2010-08-05 |
FDA designates XOMA 052 orphan drug for Behcet's disease |
None |
| 2010-08-04 |
Discovery Laboratories reports net loss of $6.3 million for second-quarter 2010 |
None |
| 2010-08-04 |
Par Pharmaceutical second-quarter total net revenues decrease 37% to $255.5 million |
None |
| 2010-08-04 |
USN-DAAT to collect unused, expired prescription and OTC drugs from public |
None |
| 2010-08-04 |
Pew Prescription Project announces support for new safety legislation |
None |
| 2010-08-04 |
Patients taking memantine show improvement in cognitive function, Merz analyses shows |
None |
| 2010-08-04 |
IPS looks at anticipated impact of free-trade talks on India's generic drug industry |
None |
| 2010-08-04 |
PCV-7 vaccine introduction leads to changing patterns of hemolytic uremic syndrome |
3 |
| 2010-08-04 |
Carfilzomib could become new option for patients with relapsed myeloma, IMF says |
4 |
| 2010-08-04 |
Victory Pharma acquires assets of MiddleBrook Pharmaceuticals |
None |
| 2010-08-04 |
BARDA awards contract to develop Pfenex Expression Technology |
2 |
| 2010-08-04 |
DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision |
4 |
| 2010-08-04 |
ZymoGenetics second-quarter net loss declines to $3.8 million |
None |
| 2010-08-04 |
Dendreon second-quarter revenue increases to $2.8 million |
None |
| 2010-08-04 |
Arena reports lower net loss of $28.80M for second-quarter 2010 |
None |
| 2010-08-03 |
Warnings on stop smoking drug Champix |
5 |
| 2010-08-03 |
POZEN reports $16.2M net income for second-quarter 2010 |
None |
| 2010-08-03 |
Curis reports net loss of $2.1 million for second-quarter 2010 |
None |
| 2010-08-03 |
Emerson Ecologics to exclusively distribute Sedona Labs Pro probiotic products |
None |
| 2010-08-03 |
Oxygen Biotherapeutics collaborates with U.S. Navy to develop treatment for DCS |
None |
| 2010-08-03 |
Ketamine reduces depression in treatment-resistant bipolar disorder: Study |
5 |
| 2010-08-03 |
Survey on administrating human papillomavirus vaccine for cervical cancer prevention |
None |
| 2010-08-03 |
Alphavirus vector induce immune responses in people with advanced cancer: Researchers |
None |
| 2010-08-03 |
Alphavirus vaccine blocks tumor growth in advanced cancer: Research |
None |
| 2010-08-03 |
Patrys secures funding of up to A$15 million to support advancement of clinical products |
None |
| 2010-08-02 |
Octapharma USA receives confirmation of orphan drug exclusivity from FDA for wilate |
None |
| 2010-08-02 |
Taligen Therapeutics to highlight three pipeline candidates at XXIII ICW |
None |
| 2010-08-02 |
BGU Professor awarded grant to develop target-specific, anti-cancer drugs |
None |
| 2010-08-02 |
Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research |
None |
| 2010-08-02 |
U.S. gastroenterologists prescribe Abbott's Humira off-label for treating ulcerative colitis: Report |
3 |
| 2010-08-02 |
Repligen receives three additional grants to develop HDAC inhibitors for neurodegenerative diseases |
None |
| 2010-08-02 |
Osteologix grants Servier Research Group exclusive license to develop, commercialize NB S101 |
None |
| 2010-08-02 |
Inergetics receives initial purchase order from New Marketlink for Resurgex Select |
None |
| 2010-08-02 |
Xeomin receives FDA approval for treatment of cervical dystonia |
None |
| 2010-08-02 |
Almac's solutions to support biopharma companies by adopting biomarker strategies |
None |
| 2010-08-01 |
Painkiller combinations cost more but are less effective: Report |
1 |